Avita Medical | 1811094D - Loan Capital



Avita Medical reported AUD42.24M in Loan Capital for its fiscal semester ending in December of 2024.


Loan Capital Change Date
Adcock Ingram Holdings ZAR 220.08M 18M Dec/2024
Celltrion KRW 114.04B 8.35B Mar/2025
Clinuvel Pharmaceuticals AUD 509.92K 203.14K Jun/2024
Cochlear AUD 203.5M 1.4M Dec/2024
CSL USD 9.33B 1.91B Dec/2024
Cspc Pharmaceutical CNY 56.14M 10.18M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd 20M 0 Mar/2025
Kangmei Pharma CNY 84.24M 3.67M Jun/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 101.36M 20.86M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Mayne Pharma AUD 31.64M 1.47M Jun/2024
Medical Developments International AUD 1.76M 150K Dec/2024
Nanosonics AUD 5.78M 385K Dec/2024
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 52.8M 9.51M Jun/2025
Pacific Edge NZD 1.77M 744K Sep/2024
Paradigm Biopharmaceuticals AUD 100K 79.43K Dec/2024
Pharma Mar EUR 37.57M 2.66M Jun/2025
Polynovo AUD 12.84M 857K Jun/2024
PYC Therapeutics AUD 827.09K 24.09K Dec/2024
Qiagen NV USD 884.85M 467.8M Jun/2025
Ramsay Health Care AUD 10.69B 359.3M Dec/2024
ResMed USD 658.39M 4.47M Jun/2025
Sartorius EUR 4.09B 112.3M Jun/2025
Sino Biopharmaceutical CNY 2.08B 915.48M Dec/2024
Telix Pharmaceuticals AUD 551.82M 533.46M Dec/2024
Tilray USD 316.63M 15.02M Nov/2024
Zz Pientze Pharmaceu 196.31M 8.23M Jun/2025